Literature DB >> 2434607

A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.

T Skern, C Neubauer, L Frasel, P Gründler, W Sommergruber, M Zorn, E Kuechler, D Blaas.   

Abstract

Use has been made of a monoclonal antibody (designated 8F5) to map a neutralizing epitope on the viral capsid protein VP2 of human rhinovirus 2 (HRV2). This antibody which was raised against the native virus, neutralizes HRV2 and is also capable of recognizing denatured VP2 on Western blots. To examine the binding site of 8F5, VP2 of HRV2 was expressed in Escherichia coli. Deletions starting at the 3' end were then introduced into the gene for VP2 using Bal-31 nuclease. Polypeptides shortened at the carboxy terminus of VP2 were obtained from the deletions and were blotted onto nitrocellulose. The samples were then probed with monoclonal antibody 8F5. Recognition by 8F5 was maintained as long as the expressed polypeptide contained the VP2 sequence up to amino acid 164 or beyond. However, when the VP2 sequence was truncated to amino acid 153 or less 8F5 was no longer able to bind. The neutralization epitope (or part of it) recognized by 8F5 on VP2 is therefore located between amino acids 153 and 164.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434607     DOI: 10.1099/0022-1317-68-2-315

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.

Authors:  J Tormo; E Stadler; T Skern; H Auer; O Kanzler; C Betzel; D Blaas; I Fita
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

2.  Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.

Authors:  K J Wiegers; K Wetz; R Dernick
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Proteinase trapping: screening for viral proteinase mutants by alpha complementation.

Authors:  H D Liebig; T Skern; M Luderer; W Sommergruber; D Blaas; E Kuechler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Site of human rhinovirus RNA uncoating revealed by fluorescent in situ hybridization.

Authors:  Marianne Brabec-Zaruba; Beatrix Pfanzagl; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

5.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  3-Aryl-1,2,4-oxadiazole Derivatives Active Against Human Rhinovirus.

Authors:  Jinwoo Kim; Jin Soo Shin; Sunjoo Ahn; Soo Bong Han; Young-Sik Jung
Journal:  ACS Med Chem Lett       Date:  2018-04-13       Impact factor: 4.345

7.  An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections.

Authors:  Andreas Jurgeit; Stefan Moese; Pascal Roulin; Alexander Dorsch; Mark Lötzerich; Wai-Ming Lee; Urs F Greber
Journal:  Virol J       Date:  2010-10-11       Impact factor: 4.099

8.  Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras.

Authors:  Barbara Herdy; Luc Snyers; Manuela Reithmayer; Peter Hinterdorfer; Dieter Blaas
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection.

Authors:  Tuende Konecsni; Ursula Berka; Angela Pickl-Herk; Gerhard Bilek; Abdul Ghafoor Khan; Leszek Gajdzig; Renate Fuchs; Dieter Blaas
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Species-specific receptor recognition by a minor-group human rhinovirus (HRV): HRV serotype 1A distinguishes between the murine and the human low-density lipoprotein receptor.

Authors:  Manuela Reithmayer; Andrea Reischl; Luc Snyers; Dieter Blaas
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.